Showing results (771-780 of 833) with videos related to
Sort By:
Pageof 84
International Journal of Molecular Sciences|July 1, 2020
Identification of Brain-Specific Treatment Effects in NPC1 Disease by Focusing on Cellular and Molecular Changes of Sphingosine-1-Phosphate MetabolismAnne Gläser, Franziska Hammerl, Markus H Gräler, et al.Movement Disorders Clinical Practice|November 7, 2022
Validation of the OPTIMIPARK Questionnaire: A Tool to Optimize Treatment in Parkinson's DiseaseJorge U Máñez-Miró, Francisco Vivancos-Matellano, Fernando Alonso-Frech, et al.Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.Journal of Scleroderma and Related Disorders|February 2, 2019
Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group ReportJohn D Pauling, Tracy M Frech, Michael Hughes, et al.Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.Journal of Scleroderma and Related Disorders|March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working GroupsMurray Baron, Bashar Kahaleh, Elana J Bernstein, et al.Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma PatientsHadijat-Kubura M Makinde, Julia L M Dunn, Gaurav Gadhvi, et al.American Journal of Human Genetics|April 17, 2002
A major predisposition locus for severe obesity, at 4p15-p14Steven Stone, Victor Abkevich, Steven C Hunt, et al.Nature Communications|November 8, 2024
Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancyAgnes Forsthuber, Bertram Aschenbrenner, Ana Korosec, et al.The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.Pageof 84